Sentence examples for protein dosing from inspiring English sources

In combat troops, protein dosing at a minimum of 20 g of high-quality protein every 4 5 h (during waking hours) has been recommended for optimal functional recovery [64].

This in turn will decrease protein dosing and consequently will lower its toxicity [ 8].

The scientific recognition of the importance of protein is growing [ 68], and although optimal protein dosing studies are not available, expert opinion supports administering in excess of 1.2 g/kg/day [ 121, 122, 130].

In combat troops, protein dosing at a minimum of 20 g of high-quality protein every 4 5 h (during waking hours) has been recommended for optimal functional recovery [ 64].

The simulated immune responses depend on (i) protein-specific antigenic characteristics, e.g., the number of T-cell epitope, their MHC-II binding affinities, and therapeutic protein dosing regimen; and (ii) patient-specific characteristics, e.g., patient-specific MHC-II genotype and individual clearance rate for adalimumab.

A protein dosing trial has recently been completed, but until the results are available and in the absence of high-quality prospective trials designed to specifically address the issue of optimal protein intake [ 66], data from the large interventional trials using supplemental parenteral nutrition can be used to try and provide some answers.

The impact of Ab protein dose on the pharmacokinetics of anti-PD-L1 Ab was examined using 111In-DTPA-anti-PD-L1-BC 111In-DTPA-anti-PD-L1-BC 111In-DTPA-anti-PD-L1-BC 111In-DTPA-anti-PD-L1-BC 111In-DTPA-anti-PD-L1-BC 111In-DTPA-anti-PD-L1-BCe phapproximatelys of 225Ac-DOTA-anti-PD-L1-BC (15 kBq on 370g/kBq were atso examined (Fig. 1).

The range of protein doses examined in the biodistribution studies overlaps with the range examined in human studies of anti-PD-L1 Ab, which showed the blood area under the curve (AUC) increasing linearly as a function of administered Ab [2].

Blood pharmacokinetic parameters for each agent and protein dose are summarized in Table 1.

In addition, the optimization of controllable variables such as the protein dose administered.

We demonstrated that tumour uptake at 5 and 100 μg protein doses were comparable.